Indutrade Life Science

Overview

Indutrade Life Science is a business area within Indutrade, an international technology and industrial group. This division encompasses both technical trading companies and companies with proprietary products, specializing in components, medical technology products—including diagnostic tools, production equipment, and system solutions—primarily serving the pharmaceutical, healthcare, and food sectors. The companies operate in various countries, including Sweden, Denmark, Norway, Finland, the United Kingdom, Ireland, the Netherlands, Belgium, Luxembourg, Germany, France, Italy, Spain, Portugal, Switzerland, Austria, Poland, the Czech Republic, Slovakia, and Hungary. The strategy of Indutrade Life Science involves acquiring and developing companies that demonstrate high technical expertise and the ability to build enduring, close relationships with customers and suppliers. The focus is on companies that offer sustainable solutions enhancing competitiveness, manufacturing, developing, and selling components, systems, and services with high technological content. The business area operates through a decentralized organization, allowing acquired companies to retain their unique identities while benefiting from shared knowledge and expertise within the Indutrade Group. Indutrade Life Science's investment philosophy is rooted in entrepreneurship and decentralized leadership, key elements of Indutrade's success since its inception in 1978. The business area has a track record of steady growth, with net sales increasing by 1% in 2025, driven by acquisitions and positive sales development in medical product distribution. The EBITA margin also saw a slight increase, attributed to a higher gross margin and positive effects from acquisitions. This approach underscores Indutrade Life Science's commitment to fostering innovation and growth within the life science sector.